pentamidine methanesulfonate
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
antiprotozoal drug |
| gptkbp:activeIngredient |
gptkb:pentamidine
|
| gptkbp:ATCCode |
P01CX01
|
| gptkbp:CASNumber |
140-64-7
|
| gptkbp:hasCounterion |
methanesulfonate
|
| gptkbp:hasMolecularFormula |
C19H24N4O2S2
|
| https://www.w3.org/2000/01/rdf-schema#label |
pentamidine methanesulfonate
|
| gptkbp:routeOfAdministration |
intramuscular
intravenous |
| gptkbp:sideEffect |
gptkb:arrhythmia
gptkb:hypoglycemia pancreatitis nephrotoxicity hypotension |
| gptkbp:synonym |
gptkb:pentamidine_isethionate
pentamidine methanesulphonate |
| gptkbp:usedFor |
treatment of leishmaniasis
treatment of African trypanosomiasis treatment of Pneumocystis pneumonia |
| gptkbp:bfsParent |
gptkb:pentamidine
|
| gptkbp:bfsLayer |
6
|